Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial in
about
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?Population Pharmacokinetics and Pharmacodynamics of Meropenem in Nonobese, Obese, and Morbidly Obese Patients.Population Pharmacokinetics of High Dose Continuous Infusion Meropenem and Considerations for the Use in the Treatment of Infections due to KPC-Producing Klebsiella pneumoniae.What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?Meropenem Dosing Based on a Population Pharmacokinetic-Pharmacodynamic Model in Elderly Patients with Infection of the Lower Respiratory Tract.Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections.
P2860
Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial in
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pharmacokinetics and pharmacod ...... ere gram-negative bacterial in
@en
type
label
Pharmacokinetics and pharmacod ...... ere gram-negative bacterial in
@en
prefLabel
Pharmacokinetics and pharmacod ...... ere gram-negative bacterial in
@en
P2860
P1476
Pharmacokinetics and pharmacod ...... ere gram-negative bacterial in
@en
P2093
Manjunath P Pai
P2860
P2888
P304
P356
10.1007/S40262-015-0266-2
P577
2015-04-08T00:00:00Z
P6179
1032347647